Foamix Pharmaceuticals Shares Outstanding 2014-2018 | FOMX

Foamix Pharmaceuticals shares outstanding history from 2014 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Foamix Pharmaceuticals shares outstanding for the quarter ending June 30, 2018 were 0.040B, a 7.17% increase year-over-year.
  • Foamix Pharmaceuticals 2017 shares outstanding were 0.037B, a 15.85% increase from 2016.
  • Foamix Pharmaceuticals 2016 shares outstanding were 0.032B, a 14.29% increase from 2015.
  • Foamix Pharmaceuticals 2015 shares outstanding were 0.028B, a 94.52% increase from 2014.
Foamix Pharmaceuticals Annual Shares Outstanding
(Millions of Shares)
2017 37
2016 32
2015 28
2014 15
2013 11
Foamix Pharmaceuticals Quarterly Shares Outstanding
(Millions of Shares)
Q2 2018 40
Q1 2018 38
Q4 2017 37
Q3 2017 37
Q2 2017 37
Q1 2017 37
Q4 2016 32
Q3 2016 31
Q2 2016 31
Q1 2016 31
Q4 2015 28
Q3 2015 31
Q2 2015 26
Q1 2015 23
Q4 2014 20
Q3 2014 13
Q2 2014 11
Q1 2014 11
Q4 2013 0
Q3 2013 11
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.276B $0.004B
Foamix Pharmaceuticals Ltd. is a specialty pharmaceutical company. It develops and commercializes foam-based formulations acne, impetigo, and other skin conditions. The Company's lead product candidates include FMX101, which has completed a dose-ranging Phase II clinical trial for the treatment of moderate-to-severe acne; and FMX102 that has completed a Phase II clinical trial for the treatment of impetigo. It has operations primarily in the United States, Germany, and Israel. Foamix Pharmaceuticals Ltd. is headquartered in Rehovot, Israel.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.332B 11.09
Zoetis (ZTS) United States $43.403B 31.50
Tilray (TLRY) United States $15.428B 0.00
Grifols (GRFS) Spain $13.247B 16.17
Neurocrine Biosciences (NBIX) United States $9.956B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $9.380B 13.80
Nektar Therapeutics (NKTR) United States $8.465B 9.90
Ionis Pharmaceuticals (IONS) United States $6.195B 0.00
Catalent (CTLT) United States $6.036B 25.98
Sage Therapeutics (SAGE) United States $5.611B 0.00
Impax Laboratories (AMRX) United States $5.590B 29.73
United Therapeutics (UTHR) United States $5.377B 6.90
Loxo Oncology (LOXO) United States $4.834B 0.00
FibroGen (FGEN) United States $4.189B 0.00
Endo (ENDP) Ireland $3.914B 5.62
Taro Pharmaceutical Industries (TARO) Israel $3.735B 14.46
Madrigal Pharmaceuticals (MDGL) United States $2.907B 0.00
USANA Health Sciences (USNA) United States $2.648B 23.33
Aerie Pharmaceuticals (AERI) United States $2.543B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.492B 0.00
Heron Therapeutics (HRTX) United States $2.265B 0.00
TESARO (TSRO) United States $2.248B 0.00
Xencor (XNCR) United States $1.954B 0.00
PTC Therapeutics (PTCT) United States $1.922B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.856B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.591B 0.00
Portola Pharmaceuticals (PTLA) United States $1.544B 0.00
Zogenix (ZGNX) United States $1.488B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.475B 18.04
Spectrum Pharmaceuticals (SPPI) United States $1.461B 0.00
Corcept Therapeutics (CORT) United States $1.454B 22.38
TherapeuticsMD (TXMD) United States $1.285B 0.00
Tricida (TCDA) United States $1.224B 0.00
Esperion Therapeutics (ESPR) United States $1.205B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.158B 0.00
ImmunoGen (IMGN) United States $1.118B 0.00
Endocyte (ECYT) United States $1.072B 0.00
Radius Health (RDUS) United States $0.863B 0.00
Karyopharm Therapeutics (KPTI) United States $0.764B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.753B 0.00
Flexion Therapeutics (FLXN) United States $0.698B 0.00
GlycoMimetics (GLYC) United States $0.582B 0.00
Collegium Pharmaceutical (COLL) United States $0.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.549B 0.00
Dova Pharmaceuticals (DOVA) United States $0.548B 0.00
ChemoCentryx (CCXI) United States $0.531B 31.03
Dermira (DERM) United States $0.509B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.501B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.491B 0.00
Akebia Therapeutics (AKBA) United States $0.491B 0.00
ArQule (ARQL) United States $0.465B 0.00
OptiNose (OPTN) United States $0.453B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.445B 30.33
Forty Seven (FTSV) United States $0.433B 0.00
Odonate Therapeutics (ODT) United States $0.433B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.426B 0.00
Aclaris Therapeutics (ACRS) United States $0.415B 0.00
Siga Technologies (SIGA) United States $0.408B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.396B 0.00
Minerva Neurosciences (NERV) United States $0.384B 0.00
Xeris Pharmaceuticals (XERS) United States $0.377B 0.00
Aquestive Therapeutics (AQST) United States $0.376B 0.00
Zafgen (ZFGN) United States $0.368B 0.00
Mast Therapeutics (SVRA) United States $0.358B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.358B 0.00
Depomed (ASRT) United States $0.356B 0.00
Concert Pharmaceuticals (CNCE) United States $0.349B 0.00
Synergy Pharmaceuticals (SGYP) United States $0.342B 0.00
ElectroCore (ECOR) United States $0.341B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.340B 0.00
KalVista Pharmaceuticals (KALV) United States $0.334B 0.00
Majesco Entertainment (PTE) United States $0.331B 0.00
Translate Bio (TBIO) United States $0.323B 0.00
MEI Pharma (MEIP) United States $0.290B 0.00
CASI Pharmaceuticals (CASI) United States $0.283B 0.00
Tyme Technologies (TYME) United States $0.263B 0.00
Aldeyra Therapeutics (ALDX) United States $0.260B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.260B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.257B 0.00
Aratana Therapeutics (PETX) United States $0.255B 0.00
Opexa Therapeutics (ACER) United States $0.245B 0.00
IMV INC (IMV) Canada $0.241B 0.00
Neon Therapeutics (NTGN) United States $0.238B 0.00
Ocular Therapeutix (OCUL) United States $0.238B 0.00
Ardelyx (ARDX) United States $0.230B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.226B 0.00
Affimed (AFMD) Germany $0.215B 0.00
Calithera Biosciences (CALA) United States $0.212B 0.00
Melinta Therapeutics (MLNT) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.200B 0.00
Molecular Templates (MTEM) United States $0.192B 0.00
Jounce Therapeutics (JNCE) United States $0.186B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.181B 0.00
Redhill Biopharma (RDHL) Israel $0.177B 0.00
Achaogen (AKAO) United States $0.170B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.168B 0.00
India Globalization Capital (IGC) United States $0.163B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.163B 0.00
ContraFect (CFRX) United States $0.161B 0.00
MediWound (MDWD) Israel $0.160B 0.00
DURECT (DRRX) United States $0.157B 0.00
Lannett Co Inc (LCI) United States $0.156B 1.29
Avadel Pharmaceuticals (AVDL) Ireland $0.155B 0.00
Nature's Sunshine Products (NATR) United States $0.151B 0.00
BioLineRx (BLRX) Israel $0.147B 0.00
Adherex Technologies (FENC) United States $0.146B 0.00
Recro Pharma (REPH) United States $0.145B 0.00
Champions Oncology (CSBR) United States $0.141B 0.00
Infinity Pharmaceuticals (INFI) United States $0.140B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.132B 0.00
ProNAi Therapeutics (SRRA) Canada $0.128B 0.00
Neos Therapeutics (NEOS) United States $0.121B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.121B 0.00
Cardiome Pharma (CORV) Canada $0.115B 0.00
CTI BioPharma (CTIC) United States $0.113B 0.00
ENTASIS THERAPT (ETTX) United States $0.110B 0.00
Rafael Holdings (RFL) United States $0.107B 0.00
Forward Pharma (FWP) Denmark $0.100B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.086B 0.00
Iterum Therapeutics (ITRM) Ireland $0.086B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.084B 0.00
Immune Design (IMDZ) United States $0.082B 0.00
Otonomy (OTIC) United States $0.081B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.075B 0.00
Natural Alternatives (NAII) United States $0.072B 8.11
Nivalis Therapeutics (ALPN) United States $0.070B 0.00
Genocea Biosciences (GNCA) United States $0.065B 0.00
Novan (NOVN) United States $0.060B 0.00
SCYNEXIS (SCYX) United States $0.055B 0.00
Trillium Therapeutics (TRIL) Canada $0.054B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.051B 40.33
Ampio Pharmaceuticals (AMPE) United States $0.047B 0.00
Mannatechorporated (MTEX) United States $0.047B 24.87
Capnia (SLNO) United States $0.042B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.042B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.041B 0.00
KemPharm (KMPH) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
Avenue Therapeutics (ATXI) United States $0.037B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.94
Onconova Therapeutics (ONTX) United States $0.034B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.033B 0.00
IsoRay (ISR) United States $0.032B 0.00
Biomerica (BMRA) United States $0.030B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Citius Pharmaceuticals (CTXR) United States $0.027B 0.00
Aviragen Therapeutics (VXRT) United States $0.027B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.026B 9.30
Jaguar Animal Health (JAGX) United States $0.026B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.025B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
HANCOCK JAFFE (HJLI) United States $0.025B 0.00
Xenetic Biosciences (XBIO) United States $0.024B 0.00
ESSA Pharma (EPIX) Canada $0.023B 0.00
NanoViricides (NNVC) United States $0.022B 0.00
Aradigm (ARDM) United States $0.020B 0.00
Shineco (TYHT) China $0.019B 2.11
Cyanotech (CYAN) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.017B 0.00
Midatech Pharma (MTP) United Kingdom $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.012B 0.00
Skyline Medical (AIPT) United States $0.012B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.010B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.010B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.008B 0.00
Pain Therapeutics (PTIE) United States $0.008B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Apricus Biosciences (APRI) United States $0.007B 0.00
PharmAthene (ALT) United States $0.007B 0.00
Bio-Path Holdings (BPTH) United States $0.006B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.006B 0.00
Bio Blast Pharma (ORPN) Israel $0.004B 0.00
Intellipharmaceutics (IPCI) Canada $0.003B 0.00
RXi Pharmaceuticals (RXII) United States $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00